Skip to main content
Figure 2 | Breast Cancer Research

Figure 2

From: Persistence of disseminated tumor cells after neoadjuvant treatment for locally advanced breast cancer predicts poor survival

Figure 2

Survival analyses according to disseminated tumor cell (DTC) status. Kaplan-Meier plots for disease-free survival (DFS) (A), breast cancer specific survival (BCSS) (C) and overall survival (OS) (E) according to DTC status pretreatment (bone marrow aspiration 1 (BM1). DFS (B), BCSS (D) and OS (F) according to DTC status 12 months after start of neoadjuvant therapy (BM3). DTC+, ≥ 1 cytokeratin-positive cell per 2 × 106 MNC. DTC-, no cytokeratin-positive cells detected.

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us